Bexarotene (Mylan Institutional Inc.)
Welcome to the PulseAid listing for the Bexarotene drug offered from Mylan Institutional Inc.. This Retinoid [EPC],Retinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Institutional Inc. |
| NON-PROPRIETARY NAME: | Bexarotene |
| SUBSTANCE NAME: | BEXAROTENE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Retinoid [EPC],Retinoids [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, LIQUID FILLED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2016-04-15 |
| END MARKETING DATE: | 0000-00-00 |
Bexarotene HUMAN PRESCRIPTION DRUG Details:
| Item Description | Bexarotene from Mylan Institutional Inc. |
| LABELER NAME: | Mylan Institutional Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 75(mg/1) |
| START MARKETING DATE: | 2016-04-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 42292-007_9410215d-828c-454c-a44e-ad0fb0c65f68 |
| PRODUCT NDC: | 42292-007 |
| APPLICATION NUMBER: | ANDA203174 |
Other BEXAROTENE Pharmaceutical Manufacturers / Labelers:
